Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

California Designated Representative Training – for wholesalers or 3PL According to the article: “Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this […]

Read More

Here comes drug importation – Pharmaceutical Commerce

3 distinct Board-approved California Designated Representative online training classes for wholesalers, 3PL, reverse distributors. Earns a training affidavit. According to the article: “The Trump Administration wants to start a drug-importation program from Canada for both small-molecule and biologic products. The program would be a “time-limited Section 804 importation program” (SIP), with the SIP program sponsored […]

Read More

FDA Enforcement Delay of Wholesale Distributor Verification Requirement for Saleable Returns – LSPediA

3 distinct Board-approved California Designated Representative training programs for: wholesalers; third-party logistics providers; reverse distributors. Earns a Board-recognized training affidavit. “The US FDA published a compliance policy final guidance document on September 23, 2019, announcing a one-year enforcement discretion for the Wholesale Distributor Verification Requirement for Saleable Returned Drug Product. If you’re a wholesaler or […]

Read More

The Growing Trend of PBM Track-And-Trace Audits – Frier Levitt

California Designated Representative Training Courses (for wholesalers, 3PL). Earns a training affidavit accepted by the California State Board of Pharmacy. The Growing Trend of PBM Track-And-Trace Audits – Frier Levitt “Pharmacies are being asked [to] provide transaction history, transaction information, and transaction statement, and to maintain such records for not less than six years after […]

Read More

How DSCSA Changes the Licensing Landscape | Pharmaceutical Executive

California Designated Representative Training Course for 3PL (approved by the California State Board of Pharmacy) “The impact of new 3PL licensing The big license aftershock following the DSCSA earthquake came when the FDA redefined the parameters of 3PL companies. Before the passage of DSCSA, 3PL companies could be licensed as a wholesaler. Now, that’s no longer the case.” […]

Read More

TraceLink Bags $93M, Plans A.I. & Blockchain Tools for Drug Tracking – Xconomy

“Another area of interest for TraceLink is blockchains, the online, distributed ledger systems that power cryptocurrencies such as Bitcoin. TraceLink is developing blockchain-based software to help the pharma industry meet certain track and trace requirements in the U.S. Drug Supply Chain Security Act, Dahod says. He says the company will release more details about the […]

Read More